Literature DB >> 32968844

[Severe respiratory insufficiency as manifestation of a pulmonary metastasized Ewing's sarcoma].

M Schöffner1, J Fichte2, A Starl2, S Ullrich2, H-B Hopf2.   

Abstract

A previously unknown tumor led to respiratory failure due to pulmonary metastasis in a young male. The shortness of breath began gradually and then rapidly progressed within 2 weeks. With the cause of respiratory failure still unclear, extracorporeal membrane oxygenation (ECMO) treatment was initiated to gain time for the definitive diagnosis. After the exclusion of infectious lung diseases the diagnosis could be made by a biopsy. Surprisingly, a Ewing's sarcoma was diagnosed and chemotherapy was initiated. This led to tumor regression within about 3 weeks, so that the patient could be successfully weaned from ECMO treatment.

Entities:  

Keywords:  Chemotherapy; Ewing’s sarcoma; Extracorporeal membrane oxygenation (ECMO); Lung metastases; Respiratory failure

Year:  2020        PMID: 32968844     DOI: 10.1007/s00101-020-00855-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

Review 1.  Ewing's sarcoma.

Authors:  Naomi J Balamuth; Richard B Womer
Journal:  Lancet Oncol       Date:  2010-02       Impact factor: 41.316

Review 2.  A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate?

Authors:  Wala Ben Kridis; Nabil Toumi; Hadil Chaari; Afef Khanfir; Kamel Ayadi; Hassib Keskes; Tahia Boudawara; Jamel Daoud; Mounir Frikha
Journal:  Rev Recent Clin Trials       Date:  2017

Review 3.  [Extracorporeal membrane oxygenation : System selection, (contra)indications, and management].

Authors:  T Staudinger
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05       Impact factor: 0.840

4.  Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure.

Authors:  Philipp Wohlfarth; Roman Ullrich; Thomas Staudinger; Andja Bojic; Oliver Robak; Alexander Hermann; Barbara Lubsczyk; Nina Worel; Valentin Fuhrmann; Maria Schoder; Martin Funovics; Werner Rabitsch; Paul Knoebl; Klaus Laczika; Gottfried J Locker; Wolfgang R Sperr; Peter Schellongowski
Journal:  Crit Care       Date:  2014-01-20       Impact factor: 9.097

5.  The criteria of eligibility to the extracorporeal treatment.

Authors:  A Zangrillo
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.